Gujrathi Sheila
- SEC CIK
- 0001575202
No open-market purchases or sales filed in the past year.
Current role at each company
- PCSA Processa Pharmaceuticals, Inc.Directoras of Jul 30, 2026
- VTYX Ventyx Biosciences, Inc.Directoras of Mar 4, 2026
- JANX Janux Therapeutics, Inc.Directoras of Jun 13, 2025
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Gujrathi Sheila as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
VTYX Ventyx Biosciences, Inc.
Director2 trades
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Dec 26, 2024 (view filing) | Dec 23 | 3 days | Gujrathi SheilaDirector | PPurchase | +130.0K | $2.31 | +$300.3K | New position130.0K after | |
| Mar 31, 2023 (view filing) | Mar 30 | 1 day | Gujrathi SheilaDirector | SSale | −100.0K | $33.73 | −$3.37M | −100.0%0 after |